Research Paper Volume 16, Issue 14 pp 11339—11358
PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma
Figure 8. Targeting the PART1/miR-490-3p/SLC7A11 axis enhances sorafenib sensitivity in HCC cells. (A, B) The IC50 values were measured by the CCK-8 assays in the HCCLM3 and Huh7 cells. (C, D) CCK-8 assays tested the IC50 values of sorafenib in HCCLM3 and Huh7 cells transfected with siRNA-PART1.1.